4FO Ventures

Total investments

20

Average round size

7M

Portfolio companies

8

Lead investments

7

Follow on index

0.60

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyArtificial IntelligenceHealth CareRoboticsMedical DeviceMedicalWomen'sAgTechAgricultureFarming

Investments analytics

Analytics

Total investments
20
Lead investments
7
Follow on index
0.60
Investments by industry
  • Artificial Intelligence (11)
  • Biotechnology (8)
  • Medical (7)
  • Health Care (6)
  • Medical Device (5)
  • Show 14 more
Investments by region
  • Switzerland (18)
  • United States (2)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
0.75

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Aspivix 03 Dec 2018 Biotechnology, Health Care, Medical Device, Medical, Women's Early Stage Venture 1M Switzerland, Vaud
L2F 29 Jun 2021 Manufacturing, Industrial Early Stage Venture 4M United States, California, Fremont
Motion2Ai 01 Jan 2018 Software, Artificial Intelligence, Machine Learning, SaaS Seed 350K United States, California, Mountain View
Senior Runs 26 Oct 2021 Transportation, Health Care Seed United States, Virginia, Newport News

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.